Press "Enter" to skip to content

Exclusive Report on Breast Cancer Screening Test Market 2019 | Industry Drivers, Business Plans, Types, Applications, Challenges, Opportunities and Latest Trends Forecast to 2024

Breast

The “Breast Cancer Screening Test Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Breast Cancer Screening Test industry. The information available in the Breast Cancer Screening Test market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Breast Cancer Screening Test market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Breast Cancer Screening Test Market:

  • Allengers Medical Systems Limited
  • Myriad Genetics
  • Agendia BV
  • Armune BioScience Inc.
  • Metabolomic Technologies Inc.
  • Fujifilm Holdings Corporation
  • Biocrates Life Sciences AG
  • Siemens Healthineers
  • Hologic Inc.
  • Quest Diagnostics Incorporated

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099150

    Market Overview:

  • The breast cancer screening test market is expected to register a CAGR of 4.5% over the forecast period. Factors that are responsible for the growth of this market include the increasing awareness about the early detection of breast cancer, the growing incidence of breast cancer, and the increasing government initiatives and support.
  • Early detection of breast cancer can lead to desired outcomes, including increased survival rate, number of treatment options, and improved quality of life. And the rising incidence of breast cancer is helping the market to grow in the forecast period. As per the Breastcancer.org, about one in eight US women (about 12.4%) will develop invasive breast cancer over the course of their lifetime. In 2018, an estimated 266,120 new cases of invasive breast cancer are anticipated to be diagnosed in women only in the United States, along with 63,960 new cases of non-invasive breast cancer. Since there is a rising need for the breast cancer screening test across developing as well as developed nations, the demand for breast cancer screening tests is increasing which is leading to the growth of this market.

    Scope of the Report:

  • Breast cancer screening is carried out to detect cancer in its early stages and ensure timely treatment to the patients. There are different types of breast cancer depending on the type of breast cell that becomes cancerous. Breast cancer can affect different parts of the breast, such as the ducts and the lobes.

    Reasons for Buying Breast Cancer Screening Test Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099150

    Key Market Trends:

    Imaging Test is Expected to Dominate in the Breast Cancer Screening Test Segment

    The most commonly used screening test for breast cancer is the imaging test and these imaging tests are considered as the most reliable ones. Mammograms are the most widely used tests to screen breast cancer. Since mammography is the gold standard technique used to screen breast cancer, governments and other healthcare organizations around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. This is increasing the global demand for mammography while laboratory and blood tests and other imaging tests are gaining popularity. Digital breast tomosynthesis can increase the diagnostic accuracy of mammography and is used for the assessment of equivocal or suspicious mammography findings. Other modalities, such as ultrasound and contrast-enhanced magnetic resonance imaging (MRI) play an important role in the diagnostics, staging, and follow-up of breast cancer.

    North America Dominates the Market and Expected to do Same in the Forecast Period

    North America currently dominates the market for breast cancer screening test and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. This can be majorly attributed to the increasing incidence rates of breast cancer and rising awareness among the population for the early detection of cancer. The presence of the developed healthcare infrastructure is expected to propel the market in the United States.

    Breast Cancer Screening Test Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14099150

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Breast Cancer Screening Test Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Iincreasing Awareness about Early Detection of Breast Cancer
    4.2.2 Growing Incidence of Breast Cancer
    4.2.3 Increasing Government Initiatives and Support
    4.3 Market Restraints
    4.3.1 Controversies Related to Mammography
    4.3.2 High Cost of Screening Tests in the Developing Countries
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Test
    5.1.1 Genomic Tests
    5.1.1.1 MammaPrint Test
    5.1.1.2 Breast Cancer Index Test
    5.1.1.3 Mammostrat Test
    5.1.1.4 PAM50 Test
    5.1.1.5 Oncotype DX Test
    5.1.1.6 Other Genomic Tests
    5.1.2 Imaging Test
    5.1.2.1 Mammograms
    5.1.2.2 Ultrasound
    5.1.2.3 MRI
    5.1.2.4 Tomography
    5.1.2.5 Other Imaging Tests
    5.2 Geography
    5.2.1 North America
    5.2.1.1 US
    5.2.1.2 Canada
    5.2.1.3 Mexico
    5.2.2 Europe
    5.2.2.1 Germany
    5.2.2.2 UK
    5.2.2.3 France
    5.2.2.4 Italy
    5.2.2.5 Spain
    5.2.2.6 Rest of Europe
    5.2.3 Asia-Pacific
    5.2.3.1 China
    5.2.3.2 Japan
    5.2.3.3 India
    5.2.3.4 Australia
    5.2.3.5 South Korea
    5.2.3.6 Rest of Asia-Pacific
    5.2.4 Middle East & Africa
    5.2.4.1 GCC
    5.2.4.2 South Africa
    5.2.4.3 Rest of Middle East & Africa
    5.2.5 South America
    5.2.5.1 Brazil
    5.2.5.2 Argentina
    5.2.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Allengers Medical Systems Limited
    6.1.2 Myriad Genetics
    6.1.3 Agendia BV
    6.1.4 Armune BioScience Inc.
    6.1.5 Metabolomic Technologies Inc.
    6.1.6 Fujifilm Holdings Corporation
    6.1.7 Biocrates Life Sciences AG
    6.1.8 Siemens Healthineers
    6.1.9 Hologic Inc.
    6.1.10 Quest Diagnostics Incorporated

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Global 3D Home Theater Projectors Market 2019: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2024 Forecast Research Report

    Global Bulk Honey Market 2019: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2023 Forecast Research Report,

    Vending Machine Food and Beverages Market 2019-2022 Offers a Detailed Study on Development and Market Trends Adopted by Competitors

    Global E-Pharmacy Market 2024 by Growth Rate, Price, Share, Revenue, Historical Analysis, Segmentation, Types, Applications and Forecast Analysis of Key Players

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *